We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
2076
DELISTED
Revance Therapeutics, Inc.
RVNC
| $872K | ﹤0.01% |
43,339
+14,011
| +48% | +$309K |
|
|
NCOM
2077
DELISTED
National Commerce Corporation
NCOM
| $870K | ﹤0.01% |
24,166
+8,978
| +59% | +$342K |
|
2078
Kosmos Energy
KOS
$1.47B
| $865K | ﹤0.01% |
212,442
+9,813
| +5% | +$60.6K |
|
|
TBRG
2079
DELISTED
TruBridge
TBRG
| $864K | ﹤0.01% |
34,418
+5,695
| +20% | +$149K |
|
2080
Astronics
ATRO
$3.75B
| $859K | ﹤0.01% |
33,838
+7,175
| +27% | +$189K |
|
|
CWEN.A
2081
DELISTED
Clearway Energy Class A
CWEN.A
| $852K | ﹤0.01% |
50,373
+246
| +0.5% | +$4.54K |
|
|
RDUS
2082
DELISTED
Radius Recycling
RDUS
| $851K | ﹤0.01% |
39,471
+12,001
| +44% | +$314K |
|
2083
Camden National
CAC
$992M
| $849K | ﹤0.01% |
23,605
+6,695
| +40% | +$269K |
|
2084
Horizon Bancorp
HBNC
$1.05B
| $847K | ﹤0.01% |
53,679
+17,148
| +47% | +$294K |
|
2085
Gorman-Rupp
GRC
$2.23B
| $840K | ﹤0.01% |
25,922
+8,130
| +46% | +$272K |
|
|
CDR
2086
DELISTED
Cedar Realty Trust, Inc
CDR
| $838K | ﹤0.01% |
40,415
+6,599
| +20% | +$160K |
|
|
RRD
2087
DELISTED
RR Donnelley & Sons Co.
RRD
| $832K | ﹤0.01% |
209,979
+32,508
| +18% | +$169K |
|
2088
Allogene Therapeutics
ALLO
$680M
| $829K | ﹤0.01% |
+30,788
| New | +$818K |
|
2089
Origin Bancorp
OBK
$1.67B
| $829K | ﹤0.01% |
24,330
+8,507
| +54% | +$311K |
|
|
CHUY
2090
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $828K | ﹤0.01% |
46,661
+8,216
| +21% | +$185K |
|
|
TELL
2091
DELISTED
Tellurian Inc.
TELL
| $827K | ﹤0.01% |
119,037
+37,906
| +47% | +$293K |
|
2092
Center Bancorp
CNOB
$1.8B
| $824K | ﹤0.01% |
44,628
+12,804
| +40% | +$262K |
|
2093
Trupanion
TRUP
$1.23B
| $824K | ﹤0.01% |
32,345
+11,163
| +53% | +$300K |
|
2094
Digi International
DGII
$3.13B
| $820K | ﹤0.01% |
81,269
+14,509
| +22% | +$168K |
|
2095
Daktronics
DAKT
$1.05B
| $818K | ﹤0.01% |
110,496
+18,919
| +21% | +$147K |
|
2096
Bank of Marin Bancorp
BMRC
$465M
| $817K | ﹤0.01% |
19,820
+6,230
| +46% | +$255K |
|
2097
Applied Optoelectronics
AAOI
$9.97B
| $816K | ﹤0.01% |
52,877
+8,849
| +20% | +$178K |
|
2098
Manitowoc
MTW
$510M
| $815K | ﹤0.01% |
55,199
+15,253
| +38% | +$285K |
|
|
ORBC
2099
DELISTED
ORBCOMM, Inc.
ORBC
| $808K | ﹤0.01% |
97,774
+33,999
| +53% | +$317K |
|
2100
Federal Agricultural Mortgage
AGM
$2.57B
| $806K | ﹤0.01% |
13,337
+3,863
| +41% | +$256K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.